US Stock MarketDetailed Quotes
SUPN Supernus Pharmaceuticals
- 36.220
- +0.400+1.12%
Close Nov 22 16:00 ET
- 36.220
- 0.0000.00%
Post 16:48 ET
2.00BMarket Cap33.95P/E (TTM)
36.660High35.850Low208.17KVolume36.080Open35.820Pre Close7.56MTurnover0.44%Turnover Ratio1811.00P/E (Static)55.22MShares39.37052wk High1.99P/B1.73BFloat Cap25.53052wk Low--Dividend TTM47.76MShs Float61.250Historical High--Div YieldTTM2.26%Amplitude4.300Historical Low36.297Avg Price1Lot Size
Supernus Pharmaceuticals Key Stats
EPS
According to the latest financial report of Supernus Pharmaceuticals, the latest earnings per share (TTM) for the company is 0.69. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: USD
Quarterly
Loading...
FCF
Interested in knowing about Supernus Pharmaceuticals's free cash flow? The latest report shows it as 53.32M. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.
Currency: USD
Quarterly
Loading...
Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Supernus Pharmaceuticals shows that the company's current ratio is 2.20, indicating healthy liquidity.
Currency: USD
Quarterly
Loading...
Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Supernus Pharmaceuticals, the quick ratio is 1.88, indicating that the company can meet its short-term debt obligations.
Currency: USD
Quarterly
Loading...
ROE
Want to learn more about the financial health of Supernus Pharmaceuticals? The latest ROE figure is 3.92%, indicating that the company has stable profitability.
Currency: USD
Quarterly
Loading...
ROA
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Supernus Pharmaceuticals, the total asset return on investment (ROA) is 2.90%.
Currency: USD
Quarterly
Loading...
Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check Supernus Pharmaceuticals's latest financial report to see how their gross margin is doing - currently at 89.99%.
Currency: USD
Quarterly
Loading...
Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Supernus Pharmaceuticals, the net profit margin is 21.91%, which is a good sign for its profitability.
Currency: USD
Quarterly
Loading...
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data